Results 41 to 50 of about 5,756 (158)
Health Science Reports, Volume 9, Issue 8, August 2026.ABSTRACT Background and Aims Elevated resting heart rate in heart transplant (HTx) recipients due to graft denervation is associated with adverse outcomes. Ivabradine and beta blockers are commonly used for heart rate control post‐HTx, but their comparative effectiveness and safety remain unclear.
Ahmad Hassan +13 more
wiley +1 more source
ESC Heart Failure, 2019 Aims Ivabradine has been approved in heart failure with reduced ejection fraction (HFrEF) and elevated heart rate despite guideline‐directed medical therapy (GDMT) to reduce cardiovascular (CV) death and hospitalization for worsening HF. The median value
Nadia Bouabdallaoui +9 more
doaj +1 more source
How physiology solves the gene‐centric impasse
Experimental Physiology, Volume 111, Issue 8, Page 3546-3556, 1 August 2026.Abstract The criteria for distinguishing between association and causation in studies of genes and function are clarified. Genomic association scores alone cannot satisfy those criteria, which is why treatment of common diseases has not benefitted from the cures expected when the Human Genome Project was launched.
Denis Noble, Reine Bourret
wiley +1 more source
Arthritis Care &Research, Volume 78, Issue 7, Page 860-874, July 2026.Objective Sjögren's disease is an autoimmune disorder that can impact multiple organ systems, including the peripheral nervous system (PNS). PNS manifestations, which can exist concurrently, include mononeuropathies, polyneuropathies, and autonomic nervous system neuropathies.
Anahita Deboo +88 more
wiley +1 more source
Терапевтический архив, 2013 AIM: To evaluate the efficiency and safety of an interchange of atenolol and ivabradine in patients who had stable angina pectoris without myocardial infarction in the history and left ventricular (LV) systolic dysfunction/MATERIAL AND METHODS: The trial
A A Shavarov +2 more
doaj
Clinical Cardiology, Volume 49, Issue 7, July 2026.In a retrospective single‐center cohort of 109 patients who underwent CRT‐D implantation, six electrocardiographic definitions of left bundle branch block (LBBB)—Strauss, Marriott, Perrin, ESC 2013, ESC 2021, and WHO/AHA—were compared for their ability to predict outcomes after cardiac resynchronization therapy (CRT).
Athanasios Saplaouras +16 more
wiley +1 more source
Pulmonary Circulation, Volume 16, Issue 3, July 2026.ABSTRACT Pulmonary arterial hypertension (PAH) is a rare disease with poor prognosis. The same treatment is recommended in patients with PAH associated with connective tissue disease (CTD) and idiopathic PAH (IPAH). However, the effectiveness of PAH‐specific treatment in these both groups is inconsistent.
Anna Smukowska‐Gorynia +26 more
wiley +1 more source
Management of Stable Angina with Ivabradine as Safe Alternative to Patients with Myasthenia Gravis
Case Reports in Neurological Medicine, 2016 Management of cardiac symptoms in myasthenia gravis (MG) patients can be challenging. The aim of this report is to describe the safe use of ivabradine for stable angina in MG patients. A 48 y.o.
Giuliano Ohde Dalledone +7 more
doaj +1 more source
Ivabradine: Evidence and current role in cardiovascular diseases and other emerging indications
Indian Heart Journal, 2018 Increased heart rate (HR) is associated with deleterious effects on several disease conditions. Chronic heart failure (CHF) is one of the cardiovascular diseases with recurrent hospitalization burden and an ongoing drain on health-care expenditure ...
I. Sathyamurthy, Sanket Newale
doaj +1 more source
ESC Heart FailureBackground Ivabradine, a medical treatment for heart failure (HF), reduces heart rate (HR) and prolongs diastolic perfusion time. It is frequently prescribed to patients with HF who have a suboptimal response or intolerance to beta‐blockers. Degenerative
Wei‐Chieh Lee +5 more
doaj +1 more source